| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Encorafenib |
|---|
| Description | Encorafenib (LGX818) is a potent mutated BRafV600E inhibitor (IC50 = 0.3 nM) with potential antineoplastic activity. Displays little activity against wild-type B-Raf or a panel of 100 other kinases (IC50s = 900 nM). MW: 540.01. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate; LGX818 |
|---|
| Gene, Accession, CAS # | CAS: 1269440-17-6 |
|---|
| Catalog # | B2103-25 |
|---|
| Price | |
|---|
| Order / More Info | Encorafenib from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|